- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 43/295 - Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing hydroxy or O-metal groups
Patent holdings for IPC class C07C 43/295
Total number of patents in this class: 96
10-year publication summary
5
|
9
|
10
|
9
|
18
|
17
|
5
|
5
|
3
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Unigen, Inc. | 116 |
7 |
British Columbia Cancer Agency Branch | 195 |
5 |
The University of British Columbia | 1468 |
5 |
Mitsubishi Gas Chemical Company, Inc. | 3351 |
4 |
XENIOPRO GmbH | 15 |
4 |
Zhejiang Ausun Pharmaceutical Co., Ltd. | 35 |
3 |
LG Chem, Ltd. | 17657 |
2 |
Central Glass Company, Limited | 1248 |
2 |
Rhodia Operations | 1589 |
2 |
Transfert Plus, S.E.C. | 29 |
2 |
Cava Healthcare Inc. | 14 |
2 |
Nikang Therapeutics, Inc. | 86 |
2 |
Psigryph Inc. | 6 |
2 |
Goodcap Pharmaceuticals Ltd. | 3 |
2 |
Novartis AG | 11254 |
1 |
The Regents of the University of California | 19572 |
1 |
Centre National de La Recherche Scientifique | 10140 |
1 |
Industrial Technology Research Institute | 4954 |
1 |
Sumitomo Chemical Company, Limited | 8997 |
1 |
Shin-Etsu Chemical Co., Ltd. | 5460 |
1 |
Other owners | 46 |